Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors

This publication has 19 references indexed in Scilit:

• HIV resistance to reverse transcriptase inhibitors
  Biochemical Pharmacology, 1994
• Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor
  Antiviral Research, 1993
• Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors
  Antimicrobial Agents and Chemotherapy, 1993
• HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
  Journal of Medicinal Chemistry, 1992
• Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
  Proceedings of the National Academy of Sciences, 1991
• Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
  Science, 1990
• Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
  Nature, 1990
• Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
  Biochemical and Biophysical Research Communications, 1989
• A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
  Journal of Medicinal Chemistry, 1989
• Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate
  Antimicrobial Agents and Chemotherapy, 1988